help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montine, T. J.
Right arrow Articles by Graham, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montine, T. J.
Right arrow Articles by Graham, D. G.

American Journal of Pathology, Vol 148, 89-93, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures

TJ Montine, V Amarnath, ME Martin, WJ Strittmatter and DG Graham
Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

Lipid peroxidation increases with age in brain and is elevated further in Alzheimer's disease. E-4-hydroxy-2-nonenal and malondialdehyde are products of lipid peroxidation that can adduct and cross-link protein. Neurofibrillary tangles, a feature of Alzheimer's disease composed mostly of tau protein, contain cross-linked and ubiquitin-conjugated protein. In P19 neuroglial cultures, E-4-hydroxy-2-nonenal was a potent cytotoxin that cross-linked cytoskeletal proteins, including tau into high molecular weight species that were conjugated with ubiquitin. Malondialdehyde formed monoadducts with cell protein but did not cross- link and was not cytotoxic. A non-crosslinking analogue of E-4-hydroxy- 2-nonenal was not cytotoxic. E-4-Hydroxy-2-nonenal may contribute to neurodegeneration and neurofibrillary tangle formation in Alzheimer's disease.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. N. A. Hussain, G. Matar, E. Barreiro, M. Florian, M. Divangahi, and T. Vassilakopoulos
Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L996 - L1003.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. C. Burcham and S. M. Pyke
Hydralazine Inhibits Rapid Acrolein-Induced Protein Oligomerization: Role of Aldehyde Scavenging and Adduct Trapping in Cross-Link Blocking and Cytoprotection
Mol. Pharmacol., March 1, 2006; 69(3): 1056 - 1065.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. I. Moreira, K. Honda, X. Zhu, A. Nunomura, G. Casadesus, M. A. Smith, and G. Perry
Brain and brawn: Parallels in oxidative strength
Neurology, January 24, 2006; 66(1_suppl_1): S97 - S101.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
P. I. MOREIRA, M. A. SMITH, X. ZHU, A. NUNOMURA, R. J. CASTELLANI, and G. PERRY
Oxidative Stress and Neurodegeneration
Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 545 - 552.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Sowell, B. Frei, and J. F. Stevens
Vitamin C conjugates of genotoxic lipid peroxidation products: Structural characterization and detection in human plasma
PNAS, December 28, 2004; 101(52): 17964 - 17969.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Schutt, M. Bergmann, F. G. Holz, and J. Kopitz
Proteins Modified by Malondialdehyde, 4-Hydroxynonenal, or Advanced Glycation End Products in Lipofuscin of Human Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3663 - 3668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Wataya, A. Nunomura, M. A. Smith, S. L. Siedlak, P. L. R. Harris, S. Shimohama, L. I. Szweda, M. A. Kaminski, J. Avila, D. L. Price, et al.
High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal
J. Biol. Chem., February 8, 2002; 277(7): 4644 - 4648.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R. L. Russell, C. S. Atwood, A. B. Johnson, Y. Kress, H. V. Vinters, M. Tabaton, et al.
Mitochondrial Abnormalities in Alzheimer's Disease
J. Neurosci., May 1, 2001; 21(9): 3017 - 3023.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. J. ROBERTS II, R. G. SALOMON, J. D. MORROW, and C. J. BRAME
New developments in the isoprostane pathway: identification of novel highly reactive {gamma}-ketoaldehydes (isolevuglandins) and characterization of their protein adducts
FASEB J, July 1, 1999; 13(10): 1157 - 1168.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. Nunomura, G. Perry, M. A. Pappolla, R. Wade, K. Hirai, S. Chiba, and M. A. Smith
RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer's Disease
J. Neurosci., March 15, 1999; 19(6): 1959 - 1964.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. J. Mark, Z. Pang, J. W. Geddes, K. Uchida, and M. P. Mattson
Amyloid beta -Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation
J. Neurosci., February 1, 1997; 17(3): 1046 - 1054.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.